AKT1 and cholangiocarcinoma: Proteogenomic study has elucidated the significance of the PI3K/AKT/mTOR and MAPK pathways in CCA, with their hyperactivation being correlated with unfavorable prognosis and resistance to targeted therapy [92,128].